Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
Mario Cazzola,1 Paola Rogliani,1 Luigino Calzetta,2 Maria Gabriella Matera3 1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy; 2Unit of Respiratory Disease and Lung Function, Department of Medicine and Surgery, Unive...
Saved in:
Main Authors: | Cazzola M (Author), Rogliani P (Author), Calzetta L (Author), Matera MG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022) -
New Avenues for Phosphodiesterase Inhibitors in Asthma
by: Matera MG, et al.
Published: (2021) -
Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review
by: Rogliani P, et al.
Published: (2020) -
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement
by: Luigino Calzetta, et al.
Published: (2024) -
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
by: Rogliani P, et al.
Published: (2022)